MISSION VIEJO, Calif.--(BUSINESS WIRE)--Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) announced today financial results for the three months ended March 31, 2009. The Company reported a net loss of $665,000, or $0.02 per basic share, compared to a loss of $697,000, or $0.02 per basic share, for the three months ended March 31, 2008, a decrease of 5%.
